Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E

Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E

 

 

Cost-Effectiveness Analysis of Etrasimod compared with Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain
Pharmacoecon Open. 2025. doi: 10.1007/s41669-025-00619-6

Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J

 

Cost-effectiveness of community interventions to promote awareness, testing and treatment of of hepatitis B and C in the migrant population in Catalonia
Jornada Científica CIBERESP. Zaragoza. 28-29 oct 2025
POSTER

Olveira A, Domínguez-Hernández R, Cano S, Andaluz I, Castillo P, Romero M, García-Samaniego J, García A, Abadía M

 

 

Reconnecting Hepatitis C Patients Lost to Follow-Up: A targeted Strategy
Rev Esp Enferm Dig. 2025. doi: 10.17235/reed.2025.11527/2025

Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E

 

 

Cost-effectiveness analysis of etrasimod compared with biologic therapies for patients with moderate-to-severe active ulcerative colitis experienced to previous advanced therapies in Spain
United European Gastroenterology (UEG) Week. Berlin. 4-7 oct 2025

Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J

 

Las intervenciones comunitarias para promover la sensibilización, el diagnóstico y el tratamiento de la hepatitis B y C en la población migrante en Cataluña son coste-efectivas
X Congreso Nacional GEHEP. A Coruña. 25-27 sep 2025
POSTER

Cebrián-Cuenca AM, Ampudia-Blasco FJ, Bellido-Castañeda V, Carretero-Gómez J, Gómez-Peralta F, Hernández-Martínez AM, Mezquita-Raya P, de la Cuadra-Grande A, Oyagüez I, Robles-Plaza M

 

FreeStyle Libre glucose monitoring systems in people with T2D on basal insulin: A cost-analysis from the Spanish healthcare system perspective
25th WONCA World Conference. Lisboa. 17-21 sep 2025

de la Cuadra-Grande A, Rejas J, Casado MA, Monroy M, Ruiz M

 

 

Quality of life measures in Parkinson’s disease: a systematic literature review of patient-reported outcomes measures (PROMs) and their psychometric properties
J Neurol. 2025;272(9):598. doi: 10.1007/s00415-025-13348-x

Ampudia-Blasco FJ, de la Cuadra-Grande A, Bellido-Castañeda V, Cebrián-Cuenca AM, Mezquita-Raya P, Carretero-Gómez J, Hernández Martínez AM, Oyagüez I, Gómez-Peralta F.

 

Cost analysis of the FreeStyle Libre systems in people with type 2 diabetes mellitus on basal insulin with poor glycemic control: a Spanish perspective
Diabetes Technol Ther. 2025. doi: 10.1177/15209156251363576

Cabezas J, Aguilera A, García F, Domínguez-Hernández R, Casado-Gómez A, Espinoza-Cámac N, Casado MA, Crespo J, Task Force Spanish Group for Comprehensive Hepatitis Diagnosis

 

Recommendations to practice: tracking the national rollout of comprehensive hepatitis diagnosis in Spain.
Rev Esp Enferm Dig. 2025;117. doi: 10.17235/reed.2025.11496/2025

Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos, M,Espinoza-Cámac N, OyagüezI, Del Río T, Rodríguez M

 

 

Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain
Expert Rev Pharmacoecon Outcomes Res. 2025;25(9):1337-1343. doi: 10.1080/14737167.2025.2556693